» Articles » PMID: 10405705

The Tetracyclines

Overview
Journal Mayo Clin Proc
Specialty General Medicine
Date 1999 Jul 16
PMID 10405705
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The tetracyclines, among the first of the antibiotics to become available 50 years ago, remain widely used. Tetracyclines have bacteriostatic activity against a wide variety of pathogens that are responsible for many common and some exotic infections. They are particularly valuable in the treatment of atypical pneumonia syndromes, chlamydial genital infections, rickettsial infection (Rocky Mountain spotted fever, typhus, Q fever), Lyme disease, and ehrlichiosis. On the basis of pharmacokinetic considerations, doxycycline is the preferred agent among the tetracycline congeners. Minocycline may have a limited role in the treatment of methicillin-resistant staphylococcal disease in situations in which an oral antimicrobial agent may be appropriate. The tetracyclines are generally contraindicated during pregnancy and childhood because of their association with dental staining and interference with bone growth. Photosensitivity may occur with some tetracyclines, and several drug and food interactions may limit gastrointestinal absorption.

Citing Articles

Safety profiles of doxycycline, minocycline, and tigecycline in pediatric patients: a real-world pharmacovigilance analysis based on the FAERS database.

Qiao Y, Chen Y, Wang Q, Liu J, Guo X, Gu Q Front Pharmacol. 2024; 15:1413944.

PMID: 39135789 PMC: 11317777. DOI: 10.3389/fphar.2024.1413944.


Integrated Information for Pathogenicity and Treatment of Spiroplasma.

You Y, Xiao J, Chen J, Li Y, Li R, Zhang S Curr Microbiol. 2024; 81(8):252.

PMID: 38953991 DOI: 10.1007/s00284-024-03730-9.


News in pharmacology for the main medical pathologies of gestation.

Quintana-Coronado M, Bravo C, Alvarez-Mon M, Ortega M, De Leon-Luis J Front Pharmacol. 2024; 14:1240032.

PMID: 38239189 PMC: 10794658. DOI: 10.3389/fphar.2023.1240032.


Review of Teratogenic Effects of Leflunomide, Accutane, Thalidomide, Warfarin, Tetracycline, and Angiotensin-Converting Enzyme Inhibitors.

Abadie R, Keller C, Jones N, Mayeux E, Klapper R, Anderson L Cureus. 2024; 15(12):e50465.

PMID: 38222129 PMC: 10786328. DOI: 10.7759/cureus.50465.


Efficacy and safety of antibiotic agents in the treatment of rosacea: a systemic network meta-analysis.

Xiao W, Chen M, Wang B, Huang Y, Zhao Z, Deng Z Front Pharmacol. 2023; 14:1169916.

PMID: 37251342 PMC: 10210163. DOI: 10.3389/fphar.2023.1169916.